Bio-Techne (TECH) Intangibles (2009 - 2026)
Bio-Techne (TECH) recorded quarterly Intangibles of $895.9 million in Q1 2026, up 167.44% quarter-over-quarter from $335.0 million in Q4 2025, and up 101.91% on a YoY basis from $443.7 million in Q1 2025.
Bio-Techne (TECH) Intangibles (2009 - 2026) Analysis & Trends
Bio-Techne's Intangibles history runs 18 years deep, the most recent figure standing at $895.9 million for Q1 2026.
- In Q1 2026, Intangibles rose 101.91% year-over-year to $895.9 million; the TTM figure through Mar 2026 stood at $895.9 million (up 101.91% YoY), while the FY2025 annual figure was $997.7 million, up 1402.49% from the prior year.
- Intangibles was $895.9 million for Q1 2026 at Bio-Techne, up from $335.0 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $997.7 million in Q2 2025 to a low of $66.4 million in Q4 2023.
- Historically, Intangibles has averaged $443.2 million across 5 years, with a median of $486.0 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Intangibles sank 87.58% in 2024, then soared 1402.49% in 2025.
- A 5-year view of Intangibles shows it stood at $75.6 million in 2022, then fell by 12.17% to $66.4 million in 2023, then jumped by 594.35% to $461.1 million in 2024, then dropped by 27.34% to $335.0 million in 2025, then jumped by 167.44% to $895.9 million in 2026.
- The last three Intangibles figures came in at $895.9 million (Q1 2026), $335.0 million (Q4 2025), and $350.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 4.41 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 30.30 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 418.50 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 7.73 Mn |
| 10 | Bio-Techne | 8.41 Bn | 8.20 Bn | 208.29 Mn | 895.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 895.88 Mn |
| Dec 31, 2025 | 334.99 Mn |
| Sep 30, 2025 | 350.11 Mn |
| Jun 30, 2025 | 997.65 Mn |
| Mar 31, 2025 | 443.70 Mn |
| Dec 31, 2024 | 461.05 Mn |
| Sep 30, 2024 | 486.00 Mn |
| Jun 30, 2024 | 66.40 Mn |
| Mar 31, 2024 | 66.40 Mn |
| Dec 31, 2023 | 66.40 Mn |
| Sep 30, 2023 | 578.97 Mn |
| Jun 30, 2023 | 534.65 Mn |
| Mar 31, 2023 | 530.56 Mn |
| Dec 31, 2022 | 75.60 Mn |
| Sep 30, 2022 | 562.83 Mn |
| Jun 30, 2022 | 531.52 Mn |
| Mar 31, 2022 | 551.34 Mn |
| Dec 31, 2021 | 569.35 Mn |
| Sep 30, 2021 | 615.97 Mn |
| Jun 30, 2021 | 615.97 Mn |